Facts of Gilotrif (Afatinib Boehringer Ingelheim) 20mg Capsules ?
- Medicine Name: Gilotrif
- Generic Name: Afatinib
- Date of Approval:
- Company Name: Boehringer Ingelheim Pharmaceuticals, Inc.
GILOTRIF is a prescription medicine used to treat people with non-small cell lung cancer (NSCLC),
1. that has certain types of abnormal epidermal growth factor receptor (EGFR) genes, and
2. who have not had previous treatment for cancer that has spread to other parts of the body
It is not known if GILOTRIF is safe and effective in children.
GILOTRIF is indicated for the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have epidermal growth factor receptor (EGFR) exon 19 deletions or exon 21 (L858R) substitution mutations as detected by an FDA-approved test
Keep GILOTRIF and all medicines out of the reach of children.